JAK2 pathogenic variants in ischemic stroke: low prevalence and pre-screening model
{{output}}
Objective: Our study aimed to determine the prevalence and clinical phenotypes of JAK2 pathogenic mutation carriers in the CNSR-III ischemic stroke (IS) cohort, and to develop a pre-test genetic screening model for identifying hi... ...
